The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. n.pr/4sR4fyc
n.prThe FDA gives the green light to the first gene therapy for deafnessThe treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
55 reposts249 likes